153 related articles for article (PubMed ID: 3409498)
1. Comparison of individual and combined effects of procainamide and amiodarone in patients with sustained ventricular tachyarrhythmias.
Marchlinski FE; Buxton AE; Kindwall KE; Miller JM; Rosenthal ME; Gottlieb CD; Bloom RB; Josephson ME
Circulation; 1988 Sep; 78(3):583-91. PubMed ID: 3409498
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of isoproterenol on sustained ventricular tachycardia before and during procainamide and quinidine antiarrhythmic drug therapy.
Markel ML; Miles WM; Luck JC; Klein LS; Prystowsky EN
Circulation; 1993 Mar; 87(3):783-92. PubMed ID: 8443899
[TBL] [Abstract][Full Text] [Related]
3. Predicting ventricular tachycardia cycle length after procainamide by assessing cycle length-dependent changes in paced QRS duration.
Marchlinski FE; Buxton AE; Josephson ME; Schmitt C
Circulation; 1989 Jan; 79(1):39-46. PubMed ID: 2910546
[TBL] [Abstract][Full Text] [Related]
4. Procainamide-induced changes in reentrant ventricular tachycardia with special reference to the tachycardia-interrupting critical paced cycle length during transient entrainment with rapid pacing.
Aizawa Y; Naitoh N; Washizuka T; Kitazawa H; Takahashi K; Kodama I; Shibata A
Jpn Heart J; 1994 Sep; 35(5):611-23. PubMed ID: 7830326
[TBL] [Abstract][Full Text] [Related]
5. Effects of class I and III antiarrhythmic drugs on ventricular tachycardia-interrupting critical paced cycle length with rapid pacing.
Naitoh N; Washizuka T; Takahashi K; Aizawa Y
Jpn Circ J; 1998 Apr; 62(4):267-73. PubMed ID: 9583460
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of procainamide on ventricular tachycardia: relation to prolongation of refractoriness and slowing of conduction.
Furukawa T; Rozanski JJ; Moroe K; Gosselin AJ; Lister JW
Am Heart J; 1989 Oct; 118(4):702-8. PubMed ID: 2801477
[TBL] [Abstract][Full Text] [Related]
7. Rate-dependent effects of intravenous lidocaine, procainamide and amiodarone on intraventricular conduction.
Morady F; DiCarlo LA; Baerman JM; Krol RB
J Am Coll Cardiol; 1985 Jul; 6(1):179-85. PubMed ID: 4008772
[TBL] [Abstract][Full Text] [Related]
8. Cycle-length response of ventricular tachycardia associated with coronary artery disease to procainamide and amiodarone.
Vaitkus PT; Buxton AE; Josephson ME; Marchlinski FE
Am J Cardiol; 1990 Sep; 66(7):710-4. PubMed ID: 2399887
[TBL] [Abstract][Full Text] [Related]
9. The effects of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of amiodarone and sematilide in humans.
Sager PT; Follmer C; Uppal P; Pruitt C; Godfrey R
Circulation; 1994 Oct; 90(4):1811-9. PubMed ID: 7923666
[TBL] [Abstract][Full Text] [Related]
10. Prolongation of ventricular refractoriness by class Ia antiarrhythmic drugs in the prevention of ventricular tachycardia induction.
Kus T; Costi P; Dubuc M; Shenasa M
Am Heart J; 1990 Oct; 120(4):855-63. PubMed ID: 2220538
[TBL] [Abstract][Full Text] [Related]
11. Chronic effects of amiodarone in patients with refractory ventricular tachycardia.
Saksena S; Rothbart ST; Cappello G
Int J Cardiol; 1983 Jun; 3(3):339-52. PubMed ID: 6347914
[TBL] [Abstract][Full Text] [Related]
12. Effects of incremental doses of procainamide in patients with sustained uniform ventricular tachycardia.
Grimm W; Cho JG; Marchlinski FE
J Cardiovasc Electrophysiol; 1994 Apr; 5(4):313-22. PubMed ID: 8019707
[TBL] [Abstract][Full Text] [Related]
13. Amiodarone: correlation of early and late electrophysiologic studies with outcome.
Kadish AH; Marchlinski FE; Josephson ME; Buxton AE
Am Heart J; 1986 Dec; 112(6):1134-40. PubMed ID: 3788759
[TBL] [Abstract][Full Text] [Related]
14. Prediction of antiarrhythmic efficacy of class I and III agents in patients with ventricular tachycardia by signal-averaged ECG analysis.
Kulakowski P; Bashir Y; Heald S; Paul V; Anderson MH; Gibson S; Malik M; Camm AJ
Pacing Clin Electrophysiol; 1992 Nov; 15(11 Pt 2):2116-21. PubMed ID: 1279610
[TBL] [Abstract][Full Text] [Related]
15. Response to sotalol predicts the response to amiodarone during serial drug testing in patients with sustained ventricular tachycardia and coronary artery disease.
Martínez-Rubio A; Shenasa M; Chen X; Wichter T; Breithardt G; Borggrefe M
Am J Cardiol; 1994 Feb; 73(5):357-60. PubMed ID: 7509121
[TBL] [Abstract][Full Text] [Related]
16. Amiodarone versus amiodarone and a type IA agent for treatment of patients with rapid ventricular tachycardia.
Marchlinski FE; Buxton AE; Miller JM; Vassallo JA; Flores BT; Josephson ME
Circulation; 1986 Nov; 74(5):1037-43. PubMed ID: 3769163
[TBL] [Abstract][Full Text] [Related]
17. Comparison of electrophysiologic effects of quinidine and amiodarone in sustained ventricular tachyarrhythmias associated with coronary artery disease.
Pastor A; Almendral JM; Arenal A; Lorca MT; Delcán JL
Am J Cardiol; 1993 Dec; 72(18):1389-94. PubMed ID: 8256732
[TBL] [Abstract][Full Text] [Related]
18. Procainamide induced change of the width of the zone of entrainment and its relation to the inducibility of reentrant ventricular tachycardia.
Aizawa Y; Tanabe Y; Naitoh N; Washizuka T; Shibata A; Josephson ME
Pacing Clin Electrophysiol; 1997 Nov; 20(11):2789-98. PubMed ID: 9392810
[TBL] [Abstract][Full Text] [Related]
19. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
Sager PT; Nademanee K; Antimisiaris M; Pacifico A; Pruitt C; Godfrey R; Singh BN
Circulation; 1993 Sep; 88(3):1072-82. PubMed ID: 8353869
[TBL] [Abstract][Full Text] [Related]
20. A comparison of standard and high-dose regimens for the initiation of amiodarone therapy.
Summitt J; Morady F; Kadish A
Am Heart J; 1992 Aug; 124(2):366-73. PubMed ID: 1636580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
